Stock listing
Bliss Gvs Pharma Limited
Selected listing: BLISSGVS · BSE · INR · IN
Bliss Gvs Pharma Limited (BSE:BLISSGVS), Health Technology. Latest release Jul 3, 2026: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026.
- Ticker
- BSE:BLISSGVS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BSE
- Currency
- INR
About Bliss Gvs Pharma Limited
The company is involved in the pharmaceutical sector, focusing on the development and manufacturing of various healthcare products. As a public company, it aims to deliver quality solutions to meet the needs of its customers in the healthcare industry.
Latest news from Bliss Gvs Pharma Limited
Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
July 3, 2026
IIFL Asset Management picks up nearly 2% stake in Indo Tech Transformers from promoter
June 29, 2026
Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure report
June 3, 2026
Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
June 2, 2026
Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
May 26, 2026
Research Bliss Gvs Pharma Limited
Bliss Gvs Pharma Limited company profile
View the public company page for Bliss Gvs Pharma Limited on 6ix.
Bliss Gvs Pharma Limited news
Read company news and market updates connected to Bliss Gvs Pharma Limited.
Bliss Gvs Pharma Limited investor events
Find investor webinars, events, and replay context for Bliss Gvs Pharma Limited.